Boston Scientific (BSX)
$38.76 0.02 (0.05%)
11:47 EST BSX Stock Quote Delayed 30 Minutes
Previous Close -
Market Cap 53.48B
PE Ratio 484.50
Volume (Avg. Vol.) 1.88M
Day's Range 38.57 - 39.16
52-Week Range 24.10 - 42.37
Dividend & Yield N/A (N/A)
BSX Stock Predictions, Articles, and Boston Scientific News
- From InvestorPlace
- From the Web
The market is starting to get volatile again and sector rotation is underway. Clear the decks by dumping these stocks to sell for March.
Biotech stocks offer a textbook retracement pattern. The risk is low, and the reward is high. Here's how to play it.
Whether in transportation, manufacturing or healthcare, don't touch any of these 14 AI-related stocks with a 10-foot pole. Here's why.
Biotech stocks are vulnerable to headlines, but these three have too much potential to ignore. Own them for a swing trade into 2021.
Growth stocks continue to perform well despite recent market hiccups. These five firms have the potential to keep that growth going for the long haul.
By Thomas Niel
The markets may be taking a dip, but these three healthcare stocks could be your portfolio's prescription as earnings season is in full swing.
Though the market is at all-time highs, not every stock can say the same. These three stocks to buy should reach new peaks in 2020.
Stock charts of BSX, IPG and AES are moving into position for possible swing trades.
The stock charts of BSX, UAL and GM are each at key turning points, though not all necessarily for the better.
Big names like T, MSFT and CRM are on this list that analysts rank as "strong buys." If you're looking to avoid volatility, try these.
Despite all the fear around prescription drug prices, there are some excellent healthcare stocks to buy for interested investors.
The stock charts of HPE, CNC and BSX are going to get the new trading week started on the verge of major moves.
If the market should move from bad to worse in the foreseeable future, these safe stocks to buy should shield you from the worst.
We have been managing a position in Boston Scientific (NYSE:BSX) since early mid-February of this year. BSX is a medical device company that manufactures coronary stent systems, cancer treatment catheter systems, Parkinson’s deep brain stimulation systems and more.
With the Medicare for All Act threatening to impart a radical paradigm shift, healthcare stocks are suddenly under heavy fire.
We are opening a new bullish trade on Boston Scientific (NYSE:BSX). BSX is a medical device company that manufactures coronary stent systems, cancer treatment catheter systems, Parkinson’s deep brain stimulation systems and more.
The stock charts of BSX, MDLZ and FE are at make-or-break points as of Wednesday's close. Here's what you should focus on.
The stock charts of GPS, CNP and BSX are set to get the new trading week started on a narrow path. Here's what to watch.
Navellier RatingsPowered by Portfolio Grader